Cerebain Biotech Corp. is a biomedical company, which engages in the creation and clinical development of a minimally invasive implantable device. It focuses on the discovery of products for the treatment of Alzheimer’s disease utilizing Omentum. The company was founded on December 18, 2007 and is headquartered in Costa Mesa, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Cerebain Biotech Corp?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Cerebain Biotech Corp market cap is $126,200.00.
What is the 52-week high for Cerebain Biotech Corp?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Cerebain Biotech Corp 52 week high is $0.47 as of October 11, 2025.
What is the 52-week low for Cerebain Biotech Corp?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Cerebain Biotech Corp 52 week low is $0.00 as of October 11, 2025.
What is Cerebain Biotech Corp stock price today?
Cerebain Biotech Corp stock price today is $0.0009.
What was Cerebain Biotech Corp stock price yesterday?
Cerebain Biotech Corp stock price yesterday was $0.0009.
What is the 50-day moving average of Cerebain Biotech Corp?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Cerebain Biotech Corp 50-day moving average is $0.0022.